NCT06343844

Brief Summary

Following myocardial infarction, female individuals demonstrate a poorer prognosis, characterized by elevated rates of mortality and heart failure. A primary hypothesis suggests unfavorable cardiac remodeling in women. This remodeling, defined as alterations in cardiac size and shape post-infarction, necessitates repeated non-invasive imaging for study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,650

participants targeted

Target at P75+ for not_applicable

Timeline
174mo left

Started Jul 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jul 2024Sep 2040

First Submitted

Initial submission to the registry

February 23, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

July 15, 2024

Completed
15.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2039

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2040

Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

15.3 years

First QC Date

February 23, 2024

Last Update Submit

February 6, 2026

Conditions

Keywords

Non-Interventional RegistryBiorepository Establishment

Outcome Measures

Primary Outcomes (1)

  • Asses left ventricular remodeling disparities between genders

    The primary outcome measure will be the occurrence of left ventricular remodeling (defined as a change in ventricular volume of more than 10% during follow-up) measured with cardiac imaging (echocardiography and MRI)

    baseline; 3 months and 1 year after myocardial infarction onset

Secondary Outcomes (16)

  • Evaluate the evolution of remodeling at Month 3

    3 months

  • Assess remodeling changes between inclusion and Month 12

    1 year

  • Assess the prevalence of comorbidities and their impact on the effect on the outcome: post-infarction cardiac remodeling with gender (cardiovascular risk factors, renal function, hepatic functionperipheral artery disease, way of life)

    3 months and 1 year

  • Explore prognostic disparities between men and women.

    yearly, up to 10 years

  • Evaluate lifestyle habits up to 10 years: outcome anxiety/depression

    yearly, up to 10 years

  • +11 more secondary outcomes

Study Arms (1)

case control registry

OTHER

left ventricular remodeling measurement with cardiac echography

Diagnostic Test: cardiac imaging to assess left ventricular volumes and function

Interventions

non-invasive cardiac imaging (echocardiography and MRI)

case control registry

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • First myocardial infarction with ST-segment elevation during the hospital phase
  • Coronary angiography performed within 72 hours of the infarction
  • Patient affiliated or beneficiary of a social security scheme; Signature of informed consent

You may not qualify if:

  • Patients already enrolled in the study
  • Poor understanding of the French language
  • Pregnant, breastfeeding, or postpartum women
  • Individuals deprived of liberty by judicial or administrative decision; Individuals receiving psychiatric care under coercion
  • Individuals subject to a legal protection measure; Individuals incapable of giving consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Angers

Angers, France

RECRUITING

MeSH Terms

Conditions

Myocardial InfarctionVentricular Remodeling

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisPathological Conditions, Anatomical

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2024

First Posted

April 3, 2024

Study Start

July 15, 2024

Primary Completion (Estimated)

November 1, 2039

Study Completion (Estimated)

September 1, 2040

Last Updated

February 9, 2026

Record last verified: 2026-02

Locations